Yuan Li

5.0k total citations · 1 hit paper
174 papers, 3.7k citations indexed

About

Yuan Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yuan Li has authored 174 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 51 papers in Oncology and 47 papers in Cancer Research. Recurrent topics in Yuan Li's work include Cancer-related molecular mechanisms research (29 papers), RNA modifications and cancer (23 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Yuan Li is often cited by papers focused on Cancer-related molecular mechanisms research (29 papers), RNA modifications and cancer (23 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Yuan Li collaborates with scholars based in China, United States and Germany. Yuan Li's co-authors include Hye Jin Lee, Robert M. Corn, Jie He, Zhiliang Lu, Jianbing Huang, Zhaoli Chen, Shouguo Sun, Zhenning Wang, Jaffer A. Ajani and Shumei Song and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yuan Li

160 papers receiving 3.6k citations

Hit Papers

Drug resistance and Cancer stem cells 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan Li China 32 2.4k 1.2k 649 444 427 174 3.7k
Qing Wei China 28 2.5k 1.0× 1.4k 1.2× 659 1.0× 574 1.3× 313 0.7× 92 4.1k
Silvia Zappavigna Italy 35 1.7k 0.7× 856 0.7× 805 1.2× 259 0.6× 366 0.9× 100 3.6k
Emilia Wiecheć Sweden 29 2.1k 0.9× 815 0.7× 1.1k 1.6× 383 0.9× 344 0.8× 46 3.7k
Zhiyong Wang China 39 3.1k 1.3× 645 0.5× 1.1k 1.6× 443 1.0× 418 1.0× 145 5.2k
Ji Wang China 32 2.2k 0.9× 1.2k 1.0× 556 0.9× 211 0.5× 529 1.2× 142 3.9k
Hao Yang China 29 1.6k 0.7× 1.0k 0.9× 437 0.7× 208 0.5× 410 1.0× 124 3.0k
Hongmei Zhou China 32 1.3k 0.5× 713 0.6× 886 1.4× 272 0.6× 417 1.0× 175 3.6k
Shiyong Wu United States 30 2.2k 0.9× 989 0.8× 434 0.7× 215 0.5× 234 0.5× 106 3.6k

Countries citing papers authored by Yuan Li

Since Specialization
Citations

This map shows the geographic impact of Yuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Li more than expected).

Fields of papers citing papers by Yuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Li. The network helps show where Yuan Li may publish in the future.

Co-authorship network of co-authors of Yuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Li. A scholar is included among the top collaborators of Yuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Li. Yuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ping, Xinxin Yan, Jingyi Xu, et al.. (2025). Novel therapeutic insights into pathological cardiac hypertrophy: tRF-16-R29P4PE regulates PACE4 and metabolic pathways. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1872(3). 119920–119920. 1 indexed citations
2.
Zhang, Teng, Yuan Li, Xinyu Chen, et al.. (2025). Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer. Journal of Translational Medicine. 23(1). 228–228. 3 indexed citations
3.
Li, Xia, Jiahe Liu, Xi Huang, et al.. (2025). The association of family functioning and suicide in children and adolescents: positive behavior recognition and non-suicidal self-injury as sequential mediators. Frontiers in Public Health. 13. 1505960–1505960. 1 indexed citations
4.
Xing, Zhuo, Xurui Li, Haozhe Xu, et al.. (2025). High-glucose-associated YTHDC1 lactylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy. Cell Reports. 44(4). 115545–115545. 10 indexed citations
5.
6.
Sun, Yong, Shanshan Shi, Yuan Li, et al.. (2025). Triclabendazole inhibits PKM2 nuclear localization and glycolysis by enhancing HDAC6-mediated deacetylation in lung cancer. Journal of Translational Medicine. 23(1). 1001–1001. 1 indexed citations
7.
8.
Xu, Qi, Xiaoyu Feng, Siyuan Qin, et al.. (2024). Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis. Frontiers in Oncology. 14. 1423924–1423924. 1 indexed citations
9.
Tao, Ye, et al.. (2023). Global research hot spot and trends in tinnitus treatment between 2000 and 2021: A bibliometric and visualized study. Frontiers in Neurology. 13. 1085684–1085684. 4 indexed citations
10.
Jiang, Hao, Yuan Li, Xuefei Lv, Yulin Deng, & Xiaoqiong Li. (2023). Recent advances in cascade isothermal amplification techniques for ultra-sensitive nucleic acid detection. Talanta. 260. 124645–124645. 49 indexed citations
11.
Xie, Lu, Zhenyu Cai, Hezhe Lu, et al.. (2023). Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung. Heliyon. 9(5). e15527–e15527. 2 indexed citations
12.
Li, Yuan, et al.. (2022). Alterations in degree centrality and cognitive function in breast cancer patients after chemotherapy. Brain Imaging and Behavior. 16(5). 2248–2257. 5 indexed citations
13.
Huang, Lijuan, et al.. (2022). CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer. Anticancer Research. 43(1). 115–126. 9 indexed citations
15.
Li, Yi, Wei Mu, Yuan Li, et al.. (2021). Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on 18F-FDG PET/CT. EJNMMI Research. 11(1). 108–108. 4 indexed citations
16.
Liu, Sai‐Lan, Lijuan Bian, Zexian Liu, et al.. (2020). Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma. Journal for ImmunoTherapy of Cancer. 8(1). e000205–e000205. 27 indexed citations
17.
Ding, Hui, et al.. (2020). Identification of key biomarkers and potential signaling pathway associated with poor progression of gastric cancer. Translational Cancer Research. 9(9). 5459–5472. 4 indexed citations
18.
19.
Li, Yuan, et al.. (2020). Cellular heterogeneity map of diverse immune and stromal phenotypes within breast tumor microenvironment. PeerJ. 8. e9478–e9478. 7 indexed citations
20.
Chen, Xinming, et al.. (2002). [Proliferating activity and differentiation between peripheral cells and central cells in ameloblastoma].. PubMed. 37(1). 62–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026